SC
VRTX icon

Sapient Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Sapient Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.95M Sell
18,011
-981
-5% -$435K 0.12% 89
2026
Q1 		$8.48M Sell
18,992
-15,332
-45% -$7.15M 0.13% 94
2025
Q4 		$15.6M Buy
34,324
+13
+0% +$5.6K 0.22% 71
2025
Q3 		$13.6M Sell
34,311
-1,999
-6% -$835K 0.21% 73
2025
Q2 		$16.2M Buy
36,310
+314
+0.9% +$145K 0.29% 64
2025
Q1 		$17.5M Buy
35,996
+200
+0.6% +$93.2K 0.34% 60
2024
Q4 		$14.4M Buy
35,796
+498
+1% +$231K 0.28% 67
2024
Q3 		$16.4M Buy
35,298
+43
+0.1% +$20.7K 0.33% 59
2024
Q2 		$16.5M Sell
35,255
-20
-0.1% -$8.68K 0.34% 56
2024
Q1 		$14.7M Buy
35,275
+789
+2% +$334K 0.33% 64
2023
Q4 		$14M Buy
+34,486
New +$12.7M 0.36% 61

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM

Sapient Capital's VRTX Position: Q2 2026 in Review

Sapient Capital reduced its Vertex Pharmaceuticals (VRTX) stake by 5.2% in Q2 2026, selling an estimated $435K and leaving 18,011 shares worth $8.95M. The position accounts for 0.12% of the portfolio, ranked #89.

Sapient Capital first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $17.5M in Q1 2025. 268 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Sapient Capital held 18,011 shares of Vertex Pharmaceuticals worth $8.95M as of Q2 2026.
  • Sapient Capital sold 981 Vertex Pharmaceuticals shares in Q2 2026, an estimated $435K.
  • Vertex Pharmaceuticals made up 0.12% of Sapient Capital's portfolio in Q2 2026, its #89 holding.
  • Sapient Capital first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Sapient Capital's Vertex Pharmaceuticals position peaked at $17.5M in Q1 2025.
  • 268 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.